Abstract
Cancer stem cells (CSCs), are thought to be at the origin of tumor development and resistance to therapies. Thus, a better understanding of the molecular mechanisms involved in the control of CSC stemness is essential to the design of more effective therapies for cancer patients. Cancer cell stemness and the subsequent expansion of CSCs are regulated by micro-environmental signals including neurotrophins. Over the years, the roles of neurotrophins in tumor development have been well established and regularly reviewed. Especially, nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are reported to stimulate tumor cell proliferation, survival, migration and/or invasion, and favors tumor angiogenesis. More recently, neurotrophins have been reported to regulate CSCs. This review briefly presents neurotrophins and their receptors, summarizes their roles in different cancers, and discusses the emerging evidence of neurotrophins-induced enrichment of CSCs as well as the involved signaling pathways.
Similar content being viewed by others
References
Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988. doi:10.1073/pnas.0530291100
Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401. doi:10.1038/nature03128
Curley MD, Therrien VA, Cummings CL et al (2009) CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 27:2875–2883. doi:10.1002/stem.236
O’Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106–110. doi:10.1038/nature05372
Schepers AG, Snippert HJ, Stange DE et al (2012) Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337:730–735. doi:10.1126/science.1224676
Chen J, Li Y, Yu T-SS et al (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522–526. doi:10.1038/nature11287
Driessens G, Beck B, Caauwe A et al (2012) Defining the mode of tumour growth by clonal analysis. Nature 488:527–530. doi:10.1038/nature11344
Eppert K, Takenaka K, Lechman ER et al (2011) Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 17:1086–1093. doi:10.1038/nm.2415
Liu S, Liu C, Min X et al (2013) Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis. PLoS One 8:e81050. doi:10.1371/journal.pone.0081050
Balbous A, Cortes U, Guilloteau K et al (2014) A mesenchymal glioma stem cell profile is related to clinical outcome. Oncogenesis 3:e91. doi:10.1038/oncsis.2014.5
Wicha MS (2012) Migratory gene expression signature predicts poor patient outcome: are cancer stem cells to blame? Breast Cancer Res 14:114. doi:10.1186/bcr3338
Tang DG (2012) Understanding cancer stem cell heterogeneity and plasticity. Cell Res 22:457–472. doi:10.1038/cr.2012.13
Pece S, Tosoni D, Confalonieri S et al (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140:62–73. doi:10.1016/j.cell.2009.12.007
Hope KJ, Jin L, Dick JE (2004) Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5:738–743. doi:10.1038/ni1080
Plaks V, Kong N, Werb Z (2015) The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell 16:225–238. doi:10.1016/j.stem.2015.02.015
Bresnahan PA, Leduc R, Thomas L et al (1990) Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo. J Cell Biol 111:2851–2859
Seidah NG, Benjannet S, Pareek S et al (1996) Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem J 314(Pt 3):951–960
Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4:299–309. doi:10.1038/nrn1078
Aubert L, Guilbert M, Corbet C et al (2015) NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib. Oncotarget 6:9807–9819
Hecht M, Schulte JH, Eggert A et al (2005) The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness. Carcinogenesis 26:2105–2115. doi:10.1093/carcin/bgi192
Skeldal S, Matusica D, Nykjaer A, Coulson EJ (2011) Proteolytic processing of the p75 neurotrophin receptor: a prerequisite for signalling?: Neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR). BioEssays 33:614–625. doi:10.1002/bies.201100036
Esposito D, Patel P, Stephens RM et al (2001) The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J Biol Chem 276:32687–32695. doi:10.1074/jbc.M011674200
Iacaruso MFF, Galli S, Martí M et al (2011) Structural model for p75(NTR)-TrkA intracellular domain interaction: a combined FRET and bioinformatics study. J Mol Biol 414:681–698. doi:10.1016/j.jmb.2011.09.022
Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6:603–614. doi:10.1038/nrn1726
Dang C, Zhang Y, Ma Q, Shimahara Y (2006) Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer. J Gastroenterol Hepatol 21:850–858. doi:10.1111/j.1440-1746.2006.04074.x
Ma J, Jiang Y, Jiang Y et al (2008) Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer. J Gastroenterol Hepatol 23:1852–1859. doi:10.1111/j.1440-1746.2008.05579.x
Kolokythas A, Cox DP, Dekker N, Schmidt BL (2010) Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion? J Oral Maxillofac Surg 68:1290–1295. doi:10.1016/j.joms.2010.01.006
Kobayashi K, Ando M, Saito Y et al (2015) Nerve growth factor signals as possible pathogenic biomarkers for perineural invasion in adenoid cystic carcinoma. Otolaryngol Head Neck Surg 153:218–224. doi:10.1177/0194599815584762
Davidson B, Reich R, Lazarovici P et al (2003) Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin Cancer Res 9:2248–2259
Davidson B, Konstantinovsky S, Nielsen S et al (2004) Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression. Clin Cancer Res 10:7335–7346. doi:10.1158/1078-0432.CCR-04-0183
Zhang Y, Dang C, Ma Q, Shimahara Y (2005) Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer. Oncol Rep 14:161–171
Adriaenssens E, Vanhecke E, Saule P et al (2008) Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res 68:346–351. doi:10.1158/0008-5472.CAN-07-1183
Lagadec C, Meignan S, Adriaenssens E et al (2009) TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene 28:1960–1970. doi:10.1038/onc.2009.61
Lagadec C, Romon R, Tastet C et al (2010) Ku86 is important for TrkA overexpression-induced breast cancer cell invasion. Proteomics Clin Appl 4:580–590. doi:10.1002/prca.200900148
Romon R, Adriaenssens E, Lagadec C et al (2010) Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer 9:157. doi:10.1186/1476-4598-9-157
Nico B, Mangieri D, Benagiano V et al (2008) Nerve growth factor as an angiogenic factor. Microvasc Res 75:135–141. doi:10.1016/j.mvr.2007.07.004
Nakagawara A, Arima M, Azar CG et al (1992) Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 52:1364–1368
Nakagawara A, Arima-Nakagawara M, Scavarda NJ et al (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847–854. doi:10.1056/NEJM199303253281205
Suzuki T, Bogenmann E, Shimada H et al (1993) Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85:377–384
Ho R, Minturn JE, Simpson AM et al (2011) The effect of P75 on Trk receptors in neuroblastomas. Cancer Lett 305:76–85. doi:10.1016/j.canlet.2011.02.029
Tacconelli A, Farina AR, Cappabianca L et al (2004) TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6:347–360. doi:10.1016/j.ccr.2004.09.011
Schramm A, Schowe B, Fielitz K et al (2012) Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome. Br J Cancer 107:1409–1417. doi:10.1038/bjc.2012.391
Barker PA, Lomen-Hoerth C, Gensch EM et al (1993) Tissue-specific alternative splicing generates two isoforms of the trkA receptor. J Biol Chem 268:15150–15157
Farina AR, Tacconelli A, Cappabianca L et al (2009) The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability. Mol Cell Biol 29:4812–4830. doi:10.1128/MCB.00352-09
Sasahira T, Ueda N, Yamamoto K et al (2013) Trks are novel oncogenes involved in the induction of neovascularization, tumor progression, and nodal metastasis in oral squamous cell carcinoma. Clin Exp Metastasis 30:165–176. doi:10.1007/s10585-012-9525-x
Sinkevicius KW, Kriegel C, Bellaria KJ et al (2014) Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis. Proc Natl Acad Sci USA 111:10299–10304. doi:10.1073/pnas.1404399111
Vanhecke E, Adriaenssens E, Verbeke S et al (2011) Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin Cancer Res 17:1741–1752. doi:10.1158/1078-0432.CCR-10-1890
Okugawa Y, Tanaka K, Inoue Y et al (2013) Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer. Br J Cancer 108:121–130. doi:10.1038/bjc.2012.499
Tanaka K, Okugawa Y, Toiyama Y et al (2014) Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer. PLoS One 9:e96410. doi:10.1371/journal.pone.0096410
Segal RA, Goumnerova LC, Kwon YK et al (1994) Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91:12867–12871
Eggert A, Grotzer MA, Ikegaki N et al (2001) Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms’ tumor. J Clin Oncol 19:689–696
Sclabas GM, Fujioka S, Schmidt C et al (2005) Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 11:440–449
Kawamura K, Kawamura N, Okamoto N, Manabe M (2013) Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling. Cancer Med 2:849–861. doi:10.1002/cam4.158
Eggert A, Grotzer MA, Ikegaki N et al (2002) Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells. Cancer Res 62:1802–1808
Lucarelli E, Kaplan D, Thiele CJ (1997) Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells. Eur J Cancer 33:2068–2070
Kawamura K, Kawamura N, Okamoto N et al (2013) Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling. Cancer Med 2(6):849–861. doi:10.1002/cam4.158
Kermani P, Rafii D, Jin DK et al (2005) Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest. 115(3):653–663
Jin H, Pan Y, Zhao L et al (2007) p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia 9(6):471–478
Tabassum A, Khwaja F, Djakiew D (2003) The p75(NTR) tumor suppressor induces caspase-mediated apoptosis in bladder tumor cells. Int J Cancer 105(1):47–52
Khwaja F, Tabassum A, Allen J, Djakiew D (2006) The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells. Biochem Biophys Res Commun 341(4):1184–1192
Verbeke S, Meignan S, Lagadec C et al (2010) Overexpression of p75(NTR) increases survival of breast cancer cells through p21(waf1). Cell Signal 22:1864–1873. doi:10.1016/j.cellsig.2010.07.014
Johnston AL, Lun X, Rahn JJ et al (2007) The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol 5(8):e212
Truzzi F, Marconi A, Lotti R et al (2008) Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Invest Dermatol 128(8):2031–2040. doi:10.1038/jid.2008.21
Denkins Y, Reiland J, Roy M et al (2004) Brain metastases in melanoma: roles of neurotrophins. Neuro Oncol 6(2):154–165
Marchetti D, McQuillan DJ, Spohn WC et al (1996) Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Cancer Res 56(12):2856–2863
Civenni G, Walter A, Kobert N et al (2011) Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 71(8):3098–3109. doi:10.1158/0008-5472.CAN-10-3997
Kiyosue T, Kawano S, Matsubara R et al (2013) Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma. Int J Clin Oncol 18(1):154–163. doi:10.1007/s10147-011-0358-4
Lewis Kelso R, Colome-Grimmer MI, Uchida T et al (2006) p75(NGFR) immunostaining for the detection of perineural invasion by cutaneous squamous cell carcinoma. Dermatol Surg 32(2):177–183
Tomellini E, Lagadec C, Polakowska R, Le Bourhis X (2014) Role of p75 neurotrophin receptor in stem cell biology: more than just a marker. Cell Mol Life Sci 71(13):2467–2481. doi:10.1007/s00018-014-1564-9
Xiong J, Zhou LI, Lim Y et al (2015) Mature brain-derived neurotrophic factor and its receptor TrkB are upregulated in human glioma tissues. Oncol Lett 10(1):223–227
Xiong J, Zhou L, Lim Y et al (2013) Mature BDNF promotes the growth of glioma cells in vitro. Oncol Rep 30(6):2719–2724. doi:10.3892/or.2013.2746
Lawn S, Krishna N, Pisklakova A et al (2015) Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells. J Biol Chem 290(6):3814–3824. doi:10.1074/jbc.M114.599373
Wang L, Rahn JJ, Lun X et al (2008) Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor. PLoS Biol 6(11):e289. doi:10.1371/journal.pbio.0060289
Ahn BY, Saldanha-Gama RF, Rahn JJ et al (2015) Glioma invasion mediated by the p75 neurotrophin receptor (p75NTR/CD271) requires regulated interaction with PDLIM1. Oncogene. doi:10.1038/onc.2015.199 (Epub ahead of print)
Forsyth PA, Krishna N, Lawn S et al (2014) p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells. J Biol Chem 289(12):8067–8085. doi:10.1074/jbc.M113.513762
Scala S, Wosikowski K, Giannakakou P et al (1996) Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Res 56(16):3737–3742
Jaboin J, Kim CJ, Kaplan DR, Thiele CJ (2002) Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway. Cancer Res 62(22):6756–6763
Matsumoto K, Wada RK, Yamashiro JM et al (1995) Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55(8):1798–1806
Li Z, Jaboin J, Dennis PA, Thiele CJ (2005) Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death. Cancer Res 65(6):2070–2075
Li Z, Tan F, Thiele CJ (2007) Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells. Mol Cancer Ther 6(12 Pt 1):3113–3121
Yilmaz T, Jiffar T, de la Garza G et al (2010) Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC. Cancer Biol Ther 10(6):644–653. doi:10.4161/cbt.10.6.12782
Kupferman ME, Jiffar T, El-Naggar A et al (2010) TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 29(14):2047–2059. doi:10.1038/onc.2009.486
Redmer T, Welte Y, Behrens D et al (2014) The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells. PLoS One 9(5):e92596. doi:10.1371/journal.pone.0092596
Ricci A, De Vitis C, Noto A et al (2013) TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung. Cell Cycle 12(11):1696–1703. doi:10.4161/cc.24759
Wang W, Zhao H, Zhang S et al (2009) Patterns of expression and function of the p75(NGFR) protein in pancreatic cancer cells and tumours. Eur J Surg Oncol 35(8):826–832. doi:10.1016/j.ejso.2008.10.013
Davidson B, Reich R, Lazarovici P et al (2004) Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat 83(2):119–128
Descamps S, Toillon RA, Adriaenssens E et al (2001) Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem 276(21):17864–17870
Tagliabue E, Castiglioni F, Ghirelli C et al (2000) Nerve growth factor cooperates with p185(HER2) in activating growth of human breast carcinoma cells. J Biol Chem 275(8):5388–5394
Verbeke S, Tomellini E, Dhamani F et al (2013) Extracellular cleavage of the p75 neurotrophin receptor is implicated in its pro-survival effect in breast cancer cells. FEBS Lett 587(16):2591–2596. doi:10.1016/j.febslet.2013.06.039
Yin B, Ma ZY, Zhou ZW et al (2015) The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model. Oncogene 34(6):761–770. doi:10.1038/onc.2014.8
Louie E, Chen XF, Coomes A et al (2013) Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis. Oncogene 32(35):4064–4077. doi:10.1038/onc.2012.417
Fujikawa H, Tanaka K, Toiyama Y et al (2012) High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells. J Gastroenterol 47(7):775–784. doi:10.1007/s00535-012-0532-0
Sasahira T, Ueda N, Kurihara M et al (2013) Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma. Hum Pathol 44(6):1098–1106. doi:10.1016/j.humpath.2012.09.016
Ødegaard E, Staff AC, Abeler VM et al (2007) The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma. Hum Pathol 38(1):140–146
Matusica D, Skeldal S, Sykes AM et al (2013) An intracellular domain fragment of the p75 neurotrophin receptor (p75(NTR)) enhances tropomyosin receptor kinase A (TrkA) receptor function. J Biol Chem 288(16):11144–11154. doi:10.1074/jbc.M112.436469
Kommaddi RP, Thomas R, Ceni C et al (2011) Trk-dependent ADAM17 activation facilitates neurotrophin survival signaling. FASEB J 25(6):2061–2070. doi:10.1096/fj.10-173740
Ceni C, Kommaddi RP, Thomas R et al (2010) The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling. J Cell Sci 123(Pt 13):2299–2307. doi:10.1242/jcs.062612
Gallia GL, Tyler BM, Hann CL et al (2009) Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Mol Cancer Ther 8(2):386–393. doi:10.1158/1535-7163.MCT-08-0680
Eyler CE, Foo WC, LaFiura KM et al (2008) Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 26(12):3027–3036. doi:10.1634/stemcells.2007-1073
Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361(1473):1545–1564
Bonni A, Brunet A, West AE et al (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286(5443):1358–1362
Xing J, Kornhauser JM, Xia Z et al (1998) Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol 18(4):1946–1955
Atwal JK, Singh KK, Tessier-Lavigne M et al (2003) Semaphorin 3F antagonizes neurotrophin-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase signaling: a mechanism for growth cone collapse. J Neurosci 23(20):7602–7609
Ruggeri P, Farina AR, Di Ianni N et al (2014) The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. PLoS One 9(4):e94568. doi:10.1371/journal.pone.0094568 (eCollection 2014)
Murillo-Sauca O, Chung MK, Shin JH et al (2014) CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma. Oncotarget 5(16):6854–6866
Tomellini E, Touil Y, Lagadec C et al (2015) Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment. Stem Cells 33(2):342–353. doi:10.1002/stem.1849
Morrison SJ, Kimble J (2006) Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441(7097):1068–1074
Nykjaer A, Lee R, Teng KK et al (2004) Sortilin is essential for proNGF-induced neuronal cell death. Nature 427(6977):843–848
Vaegter CB, Jansen P, Fjorback AW et al (2011) Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling. Nat Neurosci 14(1):54–61. doi:10.1038/nn.2689
Demont Y, Corbet C, Page A et al (2012) Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein. J Biol Chem 287(3):1923–1931. doi:10.1074/jbc.M110.211714
Yan Y, Zuo X, Wei D (2015) Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target. Stem Cells Transl Med 4(9):1033–1043. doi:10.5966/sctm.2015-0048
Chanmee T, Ontong P, Kimata K, Itano N (2015) Key roles of hyaluronan and its CD44 receptor in the stemness and survival of cancer stem cells. Front Oncol 5:180. doi:10.3389/fonc.2015.00180.eCollection
Zöller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11(4):254–267. doi:10.1038/nrc3023
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175):141–146
Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178–196. doi:10.1038/nrm3758
Chaffer CL, Marjanovic ND, Lee T et al (2013) Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154(1):61–74. doi:10.1016/j.cell.2013.06.005
Herreros-Villanueva M, Zhang JS, Koenig A et al (2013) SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis 2:e61. doi:10.1038/oncsis.2013.23
Guo W, Keckesova Z, Donaher JL et al (2012) Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148(5):1015–1028. doi:10.1016/j.cell.2012.02.008
Ye X, Tam WL, Shibue T et al (2015) Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 525(7568):256–260. doi:10.1038/nature14897
Götz R, Sendtner M (2014) Cooperation of tyrosine kinase receptor TrkB and epidermal growth factor receptor signaling enhances migration and dispersal of lung tumor cells. PLoS One 9(6):e100944. doi:10.1371/journal.pone.0100944.eCollection
Bao W, Wang HH, Tian FJ et al (2013) A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol Cancer 12:155. doi:10.1186/1476-4598-12-155
Bao W, Qiu H, Yang T et al (2013) Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma. PLoS One 8(7):e70616. doi:10.1371/journal.pone.0070616
Howe EN, Cochrane DR, Richer JK (2011) Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 13(2):R45. doi:10.1186/bcr2867
Smit MA, Geiger TR, Song JY et al (2009) A twist-snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 29(13):3722–3737. doi:10.1128/MCB.01164-08
Smit MA, Peeper DS (2011) Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene 30(35):3735–3744. doi:10.1038/onc.2011.96
Ricci A, Mariotta S, Pompili E et al (2010) Neurotrophin system activation in pleural effusions. Growth Factors 28(4):221–231. doi:10.3109/08977191003677402
Basak SK, Veena MS, Oh S et al (2009) The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer. PLoS One 4(6):e5884. doi:10.1371/journal.pone.0005884
Mancini R, Giarnieri E, De Vitis C et al (2011) Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment. PLoS One 6(7):e21320. doi:10.1371/journal.pone.0021320
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This research was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM), the University of Lille, the Institut National du Cancer (ARC_INCa_LNCC_8068) and the SIRIC ONCOLille.
Rights and permissions
About this article
Cite this article
Chopin, V., Lagadec, C., Toillon, RA. et al. Neurotrophin signaling in cancer stem cells. Cell. Mol. Life Sci. 73, 1859–1870 (2016). https://doi.org/10.1007/s00018-016-2156-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-016-2156-7